|
1
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA Cancer J Clin.
73:233–254. 2023.PubMed/NCBI
|
|
2
|
Arcos M, Goodla L, Kim H, Desai SP, Liu R,
Yin K, Liu Z, Martin DR and Xue X: PINK1-deficiency facilitates
mitochondrial iron accumulation and colon tumorigenesis. Autophagy.
21:737–753. 2025. View Article : Google Scholar :
|
|
3
|
Chen YJ, Hong WF, Liu ML, Guo X, Yu YY,
Cui YH, Liu TS and Liang L: An integrated bioinformatic
investigation of mitochondrial solute carrier family 25 (SLC25) in
colon cancer followed by preliminary validation of member 5
(SLC25A5) in tumorigenesis. Cell Death Dis. 13:2372022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS,
Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, et al: CAFs secreted
exosomes promote metastasis and chemotherapy resistance by
enhancing cell stemness and epithelial-mesenchymal transition in
colorectal cancer. Mol Cancer. 18:912019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao H, Ming T, Tang S, Ren S, Yang H, Liu
M, Tao Q and Xu H: Wnt signaling in colorectal cancer: Pathogenic
role and therapeutic target. Mol Cancer. 21:1442022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tran TQ, Hanse EA, Habowski AN, Li H,
Ishak Gabra MB, Yang Y, Lowman XH, Ooi AM, Liao SY, Edwards RA, et
al: α-Ketoglutarate attenuates Wnt signaling and drives
differentiation in colorectal cancer. Nat Cancer. 1:345–358. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren L, Meng L, Gao J, Lu M, Guo C, Li Y,
Rong Z and Ye Y: PHB2 promotes colorectal cancer cell proliferation
and tumorigenesis through NDUFS1-mediated oxidative
phosphorylation. Cell Death Dis. 14:442023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Duan S, Wang Y, Ling Y, Hou X,
Zhang S, Liu X, Long X, Lan J, Zhou M, et al: MYG1 drives
glycolysis and colorectal cancer development through
nuclear-mitochondrial collaboration. Nat Commun. 15:49692024.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yun SI, Kim HH, Yoon JH, Park WS, Hahn MJ,
Kim HC, Chung CH and Kim KK: Ubiquitin specific protease 4
positively regulates the WNT/β-catenin signaling in colorectal
cancer. Mol Oncol. 9:1834–1851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wijnhoven P, Konietzny R, Blackford AN,
Travers J, Kessler BM, Nishi R and Jackson SP: USP4
auto-deubiquitylation promotes homologous recombination. Mol Cell.
85:6652025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Zhou F, Drabsch Y, Gao R,
Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu
CX and ten Dijke P: USP4 is regulated by AKT phosphorylation and
directly deubiquitylates TGF-β type I receptor. Nat Cell Biol.
14:717–726. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xing C, Lu XX, Guo PD, Shen T, Zhang S, He
XS, Gan WJ, Li XM, Wang JR, Zhao YY, et al: Ubiquitin-specific
protease 4-mediated deubiquitination and stabilization of PRL-3 is
required for potentiating colorectal oncogenesis. Cancer Res.
76:83–95. 2016. View Article : Google Scholar
|
|
13
|
Toden S, Zumwalt TJ and Goel A: Non-coding
RNAs and potential therapeutic targeting in cancer. Biochim Biophys
Acta Rev Cancer. 1875:1884912021. View Article : Google Scholar
|
|
14
|
Yan H and Bu P: Non-coding RNA in cancer.
Essays Biochem. 65:625–639. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nemeth K, Bayraktar R, Ferracin M and
Calin GA: Non-coding RNAs in disease: From mechanisms to
therapeutics. Nat Rev Genet. 25:211–232. 2024. View Article : Google Scholar
|
|
16
|
Wang J, Ma X, Si H, Ma Z, Ma Y, Wang J and
Cao B: Role of long non-coding RNA H19 in therapy resistance of
digestive system cancers. Mol Med. 27:12021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shirvaliloo M: LncRNA H19 promotes tumor
angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Epigenomics. 15:61–73. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen
J, Guo R, Si J, Li L, Xue J, et al: LINC02273 drives breast cancer
metastasis by epigenetically increasing AGR2 transcription. Mol
Cancer. 18:1872019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng YC, Liu XY, Teng L, Ji Q, Wu Y, Li
JM, Gao W, Zhang YY, La T, Tabatabaee H, et al: c-Myc inactivation
of p53 through the pan-cancer lncRNA MILIP drives cancer
pathogenesis. Nat Commun. 11:49802020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He X, Yang T, Lu YW, Wu G, Dai G, Ma Q,
Zhang M, Zhou H, Long T, Yan Y, et al: The long noncoding RNA
CARDINAL attenuates cardiac hypertrophy by modulating protein
translation. J Clin Invest. 134:e1691122024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao ZT, Yang YM, Sun MM, He Y, Liao L,
Chen KS and Li B: New insights into the interplay between long
non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun
(Lond). 42:117–140. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Wang J, Deng X, Gao H, Xing F, Ding
H, Qu L and Xi Z: USPs and non-coding RNAs: Unraveling their
interplay within tumor microenvironment for targeted cancer
therapy. Pharmacol Res. 218:1078532025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu P, Xiao H, Yang Q, Hu R, Jiang L, Bi R,
Jiang X, Wang L, Mei J, Ding F and Huang J: The USP21/YY1/SNHG16
axis contributes to tumor proliferation, migration, and invasion of
non-small-cell lung cancer. Exp Mol Med. 52:41–55. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
American Veterinary Medical Associationn
(AVMA): AVMA guidelines for the euthanasia of animals: 2020
edition. AVMA; Schaumburg, IL: 2020
|
|
26
|
Morton D, Seymour M, Magill L, Handley K,
Glasbey J, Glimelius B, Palmer A, Seligmann J, Laurberg S, Murakami
K, et al: Preoperative chemotherapy for operable colon cancer:
Mature results of an international randomized controlled trial. J
Clin Oncol. 41:1541–1552. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chalabi M, Verschoor YL, Tan PB, Balduzzi
S, Van Lent AU, Grootscholten C, Dokter S, Büller NV, Grotenhuis
BA, Kuhlmann K, et al: Neoadjuvant immunotherapy in locally
advanced mismatch repair-deficient colon cancer. N Engl J Med.
390:1949–1958. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Chen J, Feng W, Huang W, Wang G,
Sun M, Luo X, Wang Y, Nie Y, Fan D, et al: FGF19-mediated ELF4
overexpression promotes colorectal cancer metastasis through
transactivating FGFR4 and SRC. Theranostics. 13:1401–1418. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bertocchi A, Carloni S, Ravenda PS,
Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D,
Asnicar F, et al: Gut vascular barrier impairment leads to
intestinal bacteria dissemination and colorectal cancer metastasis
to liver. Cancer Cell. 39:708–724.e11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tan YT, Lin JF, Li T, Li JJ, Xu RH and Ju
HQ: LncRNA-mediated posttranslational modifications and
reprogramming of energy metabolism in cancer. Cancer Commun (Lond).
41:109–120. 2021. View Article : Google Scholar :
|
|
31
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ebrahimi N, Parkhideh S, Samizade S,
Esfahani AN, Samsami S, Yazdani E, Adelian S, Chaleshtori SR,
Shah-Amiri K, Ahmadi A and Aref AR: Crosstalk between lncRNAs in
the apoptotic pathway and therapeutic targets in cancer. Cytokine
Growth Factor Rev. 65:61–74. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen
YX, Liu J, Luo XJ, Meng Q, Pu HY, et al: LncRNA LINRIS stabilizes
IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Mol Cancer. 18:1742019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu N, Jiang M, Liu H, Chu Y, Wang D, Cao
J, Wang Z, Xie X, Han Y and Xu B: LINC00941 promotes CRC metastasis
through preventing SMAD4 protein degradation and activating the
TGF-β/SMAD2/3 signaling pathway. Cell Death Differ. 28:219–232.
2021. View Article : Google Scholar
|
|
35
|
Guo Y, Jiang Z, Chen Q, Xie D, Zhou Y, Yin
W, Wang Z, Wang B, Ren C and Jiang X: Construction and experimental
validation of a signature for predicting prognosis and immune
infiltration analysis of glioma based on disulfidptosis-related
lncRNAs. Front Immunol. 14:12913852023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lang X, Huang C and Cui H: Prognosis
analysis and validation of fatty acid metabolism-related lncRNAs
and tumor immune microenvironment in cervical cancer. J Immunol
Res. 2022:49544572022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan J, Huang Z, Lin H, Cheng W, Lai J and
Li J: M7G-Related lncRNAs predict prognosis and regulate the immune
microenvironment in lung squamous cell carcinoma. BMC Cancer.
22:11322022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shin CH, Kim K, Ho CW, Lee JW, Jo MJ, Min
KW and Yoon JH: Long noncoding RNAs regulating enzymatic reactions
in cancer. Exp Mol Med. 57:1641–1650. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Segal D and Dostie J: The talented
LncRNAs: Meshing into transcriptional regulatory networks in
cancer. Cancers (Basel). 15:34332023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mehrad-Majd H, Akhtari J, Haerian MS and
Ravanshad Y: Clinicopathological and prognostic value of lncRNA
PANDAR expression in solid tumors: Evidence from a systematic
review and meta-analysis. J Cell Physiol. 234:4206–4216. 2019.
View Article : Google Scholar
|
|
41
|
Liang C, Liu J, Ge H, Xu Y, Li G and Wu J:
The clinicopathological and prognostic value of long non-coding RNA
ZEB1-AS1 in solid tumors: A meta-analysis. Clin Chim Acta.
484:91–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qiu GZ, Sun W, Jin MZ, Lin J, Lu PG and
Jin WL: The bad seed gardener: Deubiquitinases in the cancer
stem-cell signaling network and therapeutic resistance. Pharmacol
Ther. 172:127–138. 2017. View Article : Google Scholar
|
